<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1395w–151" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1395w–151/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1395w–151/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1395w_151"><akn:num>1395w–151</akn:num><akn:heading>Definitions; treatment of references to provisions in part C</akn:heading><akn:content><akn:p>§ 1395w–151. Definitions; treatment of references to provisions in part C(a) DefinitionsFor purposes of this part:(1) Basic prescription drug coverageThe term “basic prescription drug coverage” is defined in section 1395w–102(a)(3) of this title.


(2) Covered part D drugThe term “covered part D drug” is defined in section 1395w–102(e) of this title.


(3) Creditable prescription drug coverageThe term “creditable prescription drug coverage” has the meaning given such term in section 1395w–113(b)(4) of this title.


(4) Part D eligible individualThe term “part D eligible individual” has the meaning given such term in section 1395w–101(a)(3)(A) of this title.11 See References in Text note below.


(5) Fallback prescription drug planThe term “fallback prescription drug plan” has the meaning given such term in section 1395w–111(g)(4) of this title.


(6) Initial coverage limitThe term “initial coverage limit” means such limit as established under section 1395w–102(b)(3) of this title for a year before 2025, or, in the case of coverage that is not standard prescription drug coverage, the comparable limit (if any) established under the coverage for such year.


(7) Insurance riskThe term “insurance risk” means, with respect to a participating pharmacy, risk of the type commonly assumed only by insurers licensed by a State and does not include payment variations designed to reflect performance-based measures of activities within the control of the pharmacy, such as formulary compliance and generic drug substitution.


(8) MA planThe term “MA plan” has the meaning given such term in section 1395w–101(a)(3)(B) of this title.1


(9) MA–PD planThe term “MA–PD plan” has the meaning given such term in section 1395w–101(a)(3)(C) of this title.1


(10) Medicare Prescription Drug AccountThe term “Medicare Prescription Drug Account” means the Account created under section 1395w–116(a) of this title.


(11) PDP approved bidThe term “PDP approved bid” has the meaning given such term i</akn:p></akn:content><akn:subsection eId="subsec_1395w_151_a"><akn:num>(a)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(a) Definitions For purposes of this part:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_151_b"><akn:num>(b)</akn:num><akn:heading>Application of part C provisions under this part</akn:heading><akn:content><akn:p>(b) Application of part C provisions under this part For purposes of applying provisions of part C under this part with respect to a prescription drug plan and a PDP sponsor, unless otherwise provided in this part such provisions shall be applied as if—</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>